AAAAAA
Results:
1-21
|
Results: 21
Authors:
Turri, D
Rosselli, M
Simioni, P
Tormene, D
Grimaudo, S
Martorana, G
Siracusa, S
Mariani, G
Cottone, M
Citation: D. Turri et al., Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area, DIG LIVER D, 33(7), 2001, pp. 559-562
Authors:
Dragoni, F
Tormene, D
Simioni, P
Arcieri, P
Avvisati, G
Girolami, A
Citation: F. Dragoni et al., ProC global: A new automated screening assay for the evaluation of total function of the protein C system, CL APPL T-H, 7(4), 2001, pp. 351-355
Authors:
Girolami, A
Scarano, L
Tormene, D
Cella, G
Citation: A. Girolami et al., Homozygous patients with the 20210 G to A prothrombin polymorphism remain often asymptomatic in spite of the presence of associated risk factors, CL APPL T-H, 7(2), 2001, pp. 122-125
Authors:
Girolami, A
Tormene, D
Vianello, F
Citation: A. Girolami et al., Prothrombotic activity of oral contraceptives in patients with congenital thrombophilia varies with the defect, CL APPL T-H, 7(1), 2001, pp. 76-77
Authors:
Tormene, D
Simioni, P
Sartori, MT
Girolami, A
Citation: D. Tormene et al., Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebralvenous thrombosis 1 month after resumption of the medication at the age of50, BL COAG FIB, 12(2), 2001, pp. 161-162
Authors:
Tormene, D
Simioni, P
Prandoni, P
Luni, S
Zerbinati, P
Sartor, D
Franz, F
Girolami, A
Citation: D. Tormene et al., Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women, HAEMATOLOG, 86(12), 2001, pp. 1305-1309
Authors:
Simioni, P
Kalafatis, M
Tormene, D
Luni, S
Zerbinati, P
Barzon, L
Palu, G
Girolami, A
Citation: P. Simioni et al., Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma - Characterization of the dysfunctional protein C Padua(3) (Protein CR-1L/propeptide), THROMB HAEM, 86(4), 2001, pp. 1017-1022
Authors:
Simioni, P
Tormene, D
Prandoni, P
Girolami, A
Citation: P. Simioni et al., Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism, THROMB HAEM, 86(3), 2001, pp. 929-929
Authors:
Girolami, A
Tormene, D
Simioni, P
Zanon, E
Citation: A. Girolami et al., Long-term use of oral contraceptive therapy in women with the prothrombin 20210 G-A polymorphism without thrombotic complications: A study of 13 women (12 heterozygotes and 1 homozygote), THROMB RES, 102(3), 2001, pp. 205-210
Authors:
Sartori, MT
Simioni, P
Patrassi, GM
Theodoridis, P
Tormene, D
Girolami, A
Citation: Mt. Sartori et al., Combined heterozygous plasminogen deficiency and factor V Leiden defect inthe same kindred, CL APPL T-H, 6(1), 2000, pp. 36-40
Authors:
Simioni, P
Tormene, D
Luni, S
Caldato, M
Girolami, A
Citation: P. Simioni et al., Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family, BL COAG FIB, 11(4), 2000, pp. 379-384
Authors:
Girolami, A
Simioni, P
Tormene, D
Citation: A. Girolami et al., APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems, HAEMATOLOG, 85(3), 2000, pp. 225-226
Authors:
Castoldi, E
Simioni, P
Kalafatis, M
Lunghi, B
Tormene, D
Girelli, D
Girolami, A
Bernardi, F
Citation: E. Castoldi et al., Combinations of 4 mutations (FV R506Q, FVH1299R, FVY1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family, BLOOD, 96(4), 2000, pp. 1443-1448
Authors:
Simioni, P
Prandoni, P
Lensing, AWA
Manfrin, D
Tormene, D
Gavasso, S
Girolami, B
Sardella, C
Prins, M
Girolami, A
Citation: P. Simioni et al., Risk for subsequent venous thromboembolic complications in carriers of theprothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis, BLOOD, 96(10), 2000, pp. 3329-3333
Authors:
Girolami, A
Simioni, P
Manfrin, D
Tormene, D
Luni, S
Citation: A. Girolami et al., Asymptomatic homozygous nt 20210 G to A prothrombin polymorphism in two blood donors belonging to two different kindreds, CL APPL T-H, 5(1), 1999, pp. 48-51
Authors:
Girolami, A
Zanon, E
Tormene, D
Girolami, B
Carraro, G
Citation: A. Girolami et al., It is not sure yet whether the nt 20210 G to A prothrombin polymorphism represents a cause of familial venous thrombophilia, BL COAG FIB, 10(6), 1999, pp. 399-401
Authors:
Tormene, D
Simioni, P
Prandoni, P
Luni, S
Innella, B
Sabbion, P
Girolami, A
Citation: D. Tormene et al., The risk of fetal loss in family members of probands with factor V Leiden mutation, THROMB HAEM, 82(4), 1999, pp. 1237-1239
Authors:
Simioni, P
Sanson, BJ
Prandoni, P
Tormene, D
Friederich, PW
Girolami, B
Gavasso, S
Huisman, MV
Buller, HR
ten Cate, JW
Girolami, A
Prins, MH
Citation: P. Simioni et al., Incidence of venous thromboembolism in families with inherited thrombophilia, THROMB HAEM, 81(2), 1999, pp. 198-202
Authors:
Girolami, A
Simioni, P
Tormene, D
Scarano, L
Citation: A. Girolami et al., Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis, THROMB RES, 96(5), 1999, pp. 415-417
Authors:
Sanson, BJ
Simioni, P
Tormene, D
Moia, M
Friederich, PW
Huisman, MV
Prandoni, P
Bura, A
Rejto, L
Wells, P
Mannucci, PM
Girolami, A
Buller, HR
Prins, MH
Citation: Bj. Sanson et al., The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study, BLOOD, 94(11), 1999, pp. 3702-3706
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the20210A prothrombin variant
Authors:
Simioni, P
Tormene, D
Manfrin, D
Gavasso, S
Luni, S
Stocco, D
Girolami, A
Citation: P. Simioni et al., Prothrombin antigen levels in symptomatic and asymptomatic carriers of the20210A prothrombin variant, BR J HAEM, 103(4), 1998, pp. 1045-1050
Risultati:
1-21
|